Drug Shortage Report for LUVERIS
Report ID | 50104 |
Drug Identification Number | 02269066 |
Brand name | LUVERIS |
Common or Proper name | Lutropin Alpha for injection |
Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
Market Status | MARKETED |
Active Ingredient(s) | LUTROPIN ALFA |
Strength(s) | 75UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 x 75 IU vial |
ATC code | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-05-28 |
Estimated end date | |
Actual end date | 2018-06-08 |
Shortage status | Resolved |
Updated date | 2018-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-05-23 | English | Compare |
v2 | 2018-05-23 | English | Compare |
v3 | 2018-05-23 | French | Compare |
v4 | 2018-05-28 | English | Compare |
v5 | 2018-05-28 | French | Compare |
v6 | 2018-05-28 | English | Compare |
v7 | 2018-05-28 | French | Compare |
v8 | 2018-05-29 | English | Compare |
v9 | 2018-06-08 | English | Compare |
v10 | 2018-06-08 | French | Compare |
v11 | 2018-06-09 | English | Compare |
Showing 1 to 11 of 11